Filing Details

Accession Number:
0001553878-14-000013
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-15 16:54:25
Reporting Period:
2014-10-13
Filing Date:
2014-10-15
Accepted Time:
2014-10-15 16:54:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178670 Alnylam Pharmaceuticals Inc. ALNY Pharmaceutical Preparations (2834) 770602661
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226295 A Philip Sharp 300 Third Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-07-09 21,890 $0.00 74,996 No 5 J Direct
Common Stock Acquisiton 2014-10-13 100,000 $7.77 174,996 No 4 M Direct
Common Stock Acquisiton 2014-10-13 10,000 $7.08 184,996 No 4 M Direct
Common Stock Disposition 2014-10-13 110,000 $85.00 74,996 No 4 S Direct
Common Stock Disposition 2014-07-09 21,890 $0.00 191,903 No 5 J Indirect by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 J Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 5 J Indirect by Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-10-13 10,000 $0.00 10,000 $7.08
Common Stock Stock Option (right to buy) Disposition 2014-10-13 100,000 $0.00 100,000 $7.77
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2006-06-08 2015-06-08 No 4 M Direct
0 2015-05-13 No 4 M Direct
Footnotes
  1. The 21,890 shares were previously reported as indirectly owned in the (i) 15,401 shares in the Phillip A. Sharp 2009 Grantor Annuity Trust No.3 and (ii) 6,489 shares in the Phillip A. Sharp 2010 Grantor Annuity Trust No. 6. The shares were re-registered to Phillip A. Sharp.
  2. The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2014. The shares sold by the reporting person were scheduled to expire in May and June of 2015.
  3. The 191,903 shares reported as indirectly owned by trust are (i) 94,838 shares in the Phillip A. Sharp 2009 Grantor Annuity Trust No. 3, (ii) 87,399 shares in the Phillip A. Sharp 2010 Grantor Annuity Trust No. 6 and (iii) 9,666 shares in the Phillip A. Sharp 2008 Grantor Annuity Trust No. 2.
  4. The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.